v3.22.0.1
Consolidated Statements Of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2022
Jan. 31, 2021
Income Statement [Abstract]        
Revenues $ 1,856,751 $ 2,145,988 $ 5,116,741 $ 3,122,077
Cost of goods sold 1,516,970 1,576,265 4,521,974 2,351,153
Gross Margin 339,781 569,723 594,767 770,924
Operating Expenses        
Operations 334,278 146,539 794,390 353,295
Research and development 811,288 167,968 1,548,983 341,892
Sales and marketing 238,624 48,719 524,642 97,534
General and administrative 1,337,183 499,155 3,264,071 929,874
Stock based compensation 782,123 854,195 2,066,146 1,068,317
Total operating expenses 3,503,496 1,716,576 8,198,232 2,790,912
Operating loss (3,163,715) (1,146,853) (7,603,465) (2,019,988)
Other Expense (Income)        
Derivative expense 4,481,701 4,630,288
Change in fair value of derivative liability (1,026,466) 3,350,135 (1,299,527) 3,433,938
Investment income, net 363,760 402,207
Interest expense 46,596 109,712
Other, net 17,212 5,571 47,333 5,571
Other Expense (Income) (598,898) 7,837,407 (740,275) 8,069,797
Net loss $ (2,564,817) $ (8,984,260) $ (6,863,190) $ (10,089,785)
Loss per share - basic and diluted $ (0.05) $ (0.34) $ (0.15) $ (0.46)
Weighted average shares outstanding - basic and diluted 53,592,927 26,232,755 46,604,898 22,161,745

Source